IRIDEX (IRIX) vs Pulsenmore (PLSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IRIDEX is the larger company by market cap ($15.6 million vs $12.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRIX | PLSM |
|---|---|---|
| Share price | $0.89 | $1.85 |
| Market cap | $15.63M | $12.03M |
| 1-day change | -0.89% | -0.86% |
| YTD return | -21.23% | — |
| 1-year return | -17.61% | — |
| 5-year return | -87.88% | — |
| EPS (TTM) | $-0.20 | $-1.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $12.97 |
| 52-week low | $0.61 | $1.82 |
| Distance from 52-week high | -46.06% | -85.74% |
| Analyst consensus | none | — |
| Avg. price target upside | +208.99% | — |
| Average volume | 389.24K | 470.76K |
| Shares outstanding | 17.56M | 6.50M |
| Employees | 93 | 71 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IRIDEX
IRIX stock →IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 93 employees
About Pulsenmore
PLSM stock →Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe.
Health Care · Medical/Dental Instruments · 71 employees
IRIX vs PLSM FAQ
Which is bigger, IRIDEX or Pulsenmore?
IRIDEX (IRIX) is larger, with a market capitalization of $15.63M compared with $12.03M for Pulsenmore (PLSM).
Are IRIDEX and Pulsenmore in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for IRIDEX and Medical/Dental Instruments for Pulsenmore.